LPL Financial
DYN icon

LPL Financial’s Dyne Therapeutics DYN Stock Holding History

LPL Financial’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$445K Buy
20,058
+1,694
+9% +$31.5K ﹤0.01% 5115
2026
Q1 		$333K Buy
18,364
+3,114
+20% +$53.7K ﹤0.01% 5119
2025
Q4 		$298K Buy
+15,250
New +$289K ﹤0.01% 5148
2024
Q2 		– Sell
-15,114
Closed -$429K – 5050
2024
Q1 		$429K Buy
+15,114
New +$342K ﹤0.01% 3904

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

LPL Financial's DYN Position: Q2 2026 in Review

LPL Financial increased its Dyne Therapeutics (DYN) stake by 9.2% in Q2 2026, buying an estimated $31.5K and bringing the position to 20,058 shares worth $445K. The position accounts for ﹤0.01% of the portfolio, ranked #5115.

LPL Financial first reported a position in DYN in Q1 2024 and has held it in 4 quarters since. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • LPL Financial held 20,058 shares of Dyne Therapeutics worth $445K as of Q2 2026.
  • LPL Financial bought 1,694 Dyne Therapeutics shares in Q2 2026, an estimated $31.5K.
  • Dyne Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5115 holding.
  • LPL Financial first reported a position in Dyne Therapeutics in Q1 2024 and has held it in 4 quarters since.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.